Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer

Clinical trial NCT01312376 · TERMINATED

Trial details

NCT number: NCT01312376
Sponsor: Abramson Cancer Center at Penn Medicine
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Carcinoma Fallopian Tube Cancer Primary Peritoneal Cancer

Start date: 2011-03-01
Primary completion: 2015-10-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.